5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide结构式
|
常用名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide | 英文名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide |
|---|---|---|---|---|
| CAS号 | 917899-40-2 | 分子量 | 215.27300 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C8H13N3O2S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide |
|---|---|
| 英文别名 | 更多 |
| 分子式 | C8H13N3O2S |
|---|---|
| 分子量 | 215.27300 |
| 精确质量 | 215.07300 |
| PSA | 63.58000 |
| LogP | 1.49580 |
|
~74%
5-cyclopropyl-N... 917899-40-2 |
| 文献：ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 204-205 ; WO 2006/136830 A1 |
| 5-cyclopropyl-pyrazole-1-sulphonic acid dimethylamide |
| 1H-Pyrazole-1-sulfonamide,5-cyclopropyl-N,N-dimethyl |
